Need Help? Call 1­-866-­796-­7386
« back to stock screener

  KALV stock: Kalvista Pharmaceuticals Inc

Current Rating
Hold/Sell

Previous Rating

Strong Sell
Our Strong Buys
double the S&P500!
Learn more.
Company Statistics
Price
$9.32
Market Cap
257.3M
Sector
Health Care
Div. Growth
-
P/E
-
P/B
1.21
P/S
-
Dividend %
-
P/CF
5.8
P/FCF
-
Op. Cash Flow
-79.4K
FCF
-3.2
Op. Margin
-
Net Margin
-
ROE
-53.50%
ROI
-
ROA
-48.20%
EPS Growth
-17.70%
Current Ratio
16.7
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Cumberland Pharmaceuticals, In (CPIX) $1.59 - - 28M Strong Buy
Medicine Man Technologies Inc (SHWZ) $1.01 - - 59.4M Strong Buy
Spero Therapeutics Inc (SPRO) $1.77 - - 74.6M Strong Buy
KORU Medical Systems Inc (KRMD) $3.66 - - 191M Strong Buy
Emmaus Life Sciences Inc (EMMA) $0.27 - - 16.4M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More